Examination Report |
1 | TM-1 | 20 Jun 2012 |
2 | Reply to Exam Report (MIS-R) | 26 Feb 2016 |
3 | TM-5 | 15 Jul 2016 |
4 | TM-5 | 16 Aug 2016 |
5 | Journal Copy | 01 Sep 2016 |
6 | Letters related to TOP | 18 Jan 2017 |
7 | Evidence Affidavit Under Rule 45 (TOP) | 30 Oct 2017 |
8 | Evidence Affidavit Under Rule 46 (TOP) | 27 Dec 2017 |
9 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 28 Aug 2020 |
1 | Dispatching of Examination Report for : 2351939 | 2703977 | 1334413 | 08 Jan 2016 |
2 | Opposition Notice | 4204889 | 11 Nov 2016 | |
3 | Opposition Notice | 4405248 | 10 Jan 2017 | |
4 | Opposition Counter Statement | 5055472 | 23 Aug 2017 |
The application for Genpraz was made on 21 June 2012.
The trademark applicant for Genpraz is MACLEODS PHARMACEUTICALS.
Genpraz is applied in class(es) 5.
Application for Genpraz is on Opposed stage.
Application Id allotted to Genpraz is 2351939.
Trademark agent or attorney for the application is Archana Sahadeva.
Genpraz filed with the Intellectual property office as a DEVICE.